Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

State officials failed to discipline Steward for regulatory violations, check its expansion plans and cost-cutting, or ...

The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.

A health insurance company executive turned whistleblower, Wendell Potter thinks that the backlash to the industry is missing ...

After public health labs in California failed to confirm a positive result, a sample was sent to the CDC, which Thursday said ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

"Patients will die as a result of this decision," said Gayle Pledger of the Right to Breathe advocacy campaign.

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

Although research and development funding for tuberculosis reached new heights last year, the total fell substantially short ...

HHMI will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for funds to ...

Shelby Kinsey lives with a rare, fast-progressing form of ALS — but she has to spend her precious time fighting for insurance ...

As a Syrian doctor practicing in the U.S., I worry a reinstated travel ban might threaten both my potential colleagues and ...